Patient-reported outcomes in sentinel node-negative adjuvant breast cancer patients receiving sentinel-node biopsy or axillary dissection: National Surgical Adjuvant Breast and Bowel Project phase III protocol B-32.
about
Landmark trials affecting the surgical management of invasive breast cancerAxillary treatment for operable primary breast cancer.Sentinel lymph node biopsy compared with axillary lymph node dissection in early breast cancer: a meta-analysis.Treatment related impairments in arm and shoulder in patients with breast cancer: a systematic review.Survival and axillary recurrence following sentinel node-positive breast cancer without completion axillary lymph node dissection: the randomized controlled SENOMAC trialComplication rates in patients with negative axillary nodes 10 years after local breast radiotherapy after either sentinel lymph node dissection or axillary clearance.Relationship between arm morbidity and patient-reported outcomes following surgery in women with node-negative breast cancer: NSABP protocol B-32.Sentinel-lymph-node resection compared with conventional axillary-lymph-node dissection in clinically node-negative patients with breast cancer: overall survival findings from the NSABP B-32 randomised phase 3 trialQuality of life among a population-based cohort of older patients with breast cancer.Radiotherapy or surgery of the axilla after a positive sentinel node in breast cancer (EORTC 10981-22023 AMAROS): a randomised, multicentre, open-label, phase 3 non-inferiority trialEfficacy and feasibility of the immunomagnetic separation based diagnosis for detecting sentinel lymph node metastasis from breast cancer.Patterns of cellular distribution with the sentinel node positive for breast cancer.Effectiveness and cost-effectiveness of sentinel lymph node biopsy compared with axillary node dissection in patients with early-stage breast cancer: a decision model analysis.Breast cancer: from "maximum tolerable" to "minimum effective" treatmentPhysical symptoms and working performance in female breast cancer survivors: a systematic review.Breast conservation versus mastectomy for patients with T3 primary tumors (>5 cm): A review of 5685 medicare patients.Sentinel lymph node biopsy at the time of mastectomy does not increase the risk of lymphedema: implications for prophylactic surgery.A 10-year follow-up of treatment outcomes in patients with early stage breast cancer and clinically negative axillary nodes treated with tangential breast irradiation following sentinel lymph node dissection or axillary clearanceAxillary radiotherapy: an alternative treatment option for adjuvant axillary management of breast cancer.Impact of sentinel node biopsy on long-term quality of life in breast cancer patients.Tumor bed volumetric changes during breast irradiation for the patients with breast cancer.Axillary lymph node dissection in early-stage invasive breast cancer: is it still standard today?Management of the axilla in early breast cancer patients in the genomic era.Accelerated partial breast irradiation for early-stage breast cancer: controversies and current indications for use.Is DCIS breast cancer, and how do I treat it?Shoulder and arm morbidity in sentinel node-negative breast cancer patients: a systematic review.Lymphedema, musculoskeletal events and arm function in older patients receiving adjuvant chemotherapy for breast cancer (Alliance A171302).Axillary Ultrasound Accurately Excludes Clinically Significant Lymph Node Disease in Patients With Early Stage Breast Cancer.Repeated measures analyses of dermatitis symptom evolution in breast cancer patients receiving radiotherapy in a phase 3 randomized trial of mometasone furoate vs placebo (N06C4 [alliance]).Successful Completion of the Pilot Phase of a Randomized Controlled Trial Comparing Sentinel Lymph Node Biopsy to No Further Axillary Staging in Patients with Clinical T1-T2 N0 Breast Cancer and Normal Axillary Ultrasound.Expanding Implementation of ACOSOG Z0011 in Surgeon Practice.Profile and predictors of long-term morbidity in breast cancer survivors.Analysis of Undesirable Sequelae of Sentinel Node Surgery in Breast Cancer Patients - a Prospective Cohort Study.Implementation of step sectioning in the examination of sentinel lymph nodes to improve the detection of micrometastases in breast cancer patients.Systematic versus sentinel-lymph-node-driven axillary-lymph-node dissection in clinically node-negative patients with operable breast cancer. Results of the GF-GS01 randomized trial.Management of the Axilla in the Era of Breast Cancer Heterogeneity.Breast cancer-related lymphedema: risk factors, precautionary measures, and treatments
P2860
Q26830129-C8E52B23-194A-426F-9829-B04B11869AEAQ30239832-E2E411AD-D6F3-4FBF-8DC1-51E77C229D9EQ31022615-01D2A1A8-BA18-496A-8F1C-743AE990D056Q33590486-1C373162-F6EC-4D14-868E-CFE4C76BCA84Q33733790-2574F12D-B742-4901-AFF8-4770C26EA4D6Q33783188-4C427CB5-A76A-484D-8EDE-CE86B717B80BQ34039923-2A9F0A40-D73C-4500-B7C9-1E0E6F7124CEQ34139672-D3F8408E-D785-46B5-93D6-694283A546EAQ34287873-D5473524-106C-4DD7-BAF0-F76DFC05C28EQ34919537-78F5E5EC-BFB4-4D3F-B90B-79466CD5F578Q35411163-6EA481E4-79BD-4C86-9068-7EB7EB639800Q35684462-0AB514F6-7328-42E5-89C2-A06CB36AEBBCQ35832380-B616ABEC-859A-43FE-92B1-F442E351BFF6Q36302102-03DC0AFA-5656-4C2A-9A4D-F150819ECE4DQ36316883-F9D1B62D-39DA-4A57-85B0-11D60B13D428Q36447466-D6771CC3-5161-4D04-851C-2B5E66A8B50CQ36584805-218DFA0A-C6B1-4D2B-B627-12292D16AF16Q36757710-C20677E3-D7CC-42C4-ADD7-1F156C52822BQ36925117-023A8FDF-9F0D-4E56-A0D4-2042795D1146Q37352592-901B1591-DD17-4610-8230-B2CA187CA481Q37549511-C8C63A12-A5BA-4DE9-9665-FCE32CB0DEA0Q37869394-074814EC-72F4-40BC-96DB-3379CC6D8C31Q38061094-7D78B647-7EE6-4340-B721-42F81C73F5D8Q38062411-D24D86C9-68AD-4A9D-AE37-E8453325BB3BQ38067318-889632B6-7719-45DC-B37C-3E77FC3CC9C3Q38185305-8421BFC9-4FC6-4216-A6A6-16A24CC0BFD9Q38616416-731DF312-E5D7-4F08-9FEB-DD200A22A564Q38700914-BF6F743A-2648-48C6-B171-F8374E48CDCCQ38881581-6F0EEF45-EBCE-4724-8616-BF67BA808227Q42402618-6401A147-1B6D-4B88-9C6A-254FC355388EQ47662031-B27656AA-D7AB-4817-9A65-86E1BA4225E4Q48237616-F45AEEC5-D62A-49CB-874B-E667B15DB683Q50055183-00BFA5A8-BA1F-455E-B582-4D17E746E978Q50935168-93B4272B-389A-497F-9981-DA6E84888B7BQ53838470-01E968D9-4438-4BFA-9CCC-771BDC3B2FCBQ55396722-B8BCDAE3-358F-4D0E-8E6E-C89E6A517595Q57108719-69914241-6079-4570-A1B2-5D969EAAA3D1
P2860
Patient-reported outcomes in sentinel node-negative adjuvant breast cancer patients receiving sentinel-node biopsy or axillary dissection: National Surgical Adjuvant Breast and Bowel Project phase III protocol B-32.
description
2010 nî lūn-bûn
@nan
2010 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Patient-reported outcomes in s ...... oject phase III protocol B-32.
@ast
Patient-reported outcomes in s ...... oject phase III protocol B-32.
@en
Patient-reported outcomes in s ...... oject phase III protocol B-32.
@nl
type
label
Patient-reported outcomes in s ...... oject phase III protocol B-32.
@ast
Patient-reported outcomes in s ...... oject phase III protocol B-32.
@en
Patient-reported outcomes in s ...... oject phase III protocol B-32.
@nl
prefLabel
Patient-reported outcomes in s ...... oject phase III protocol B-32.
@ast
Patient-reported outcomes in s ...... oject phase III protocol B-32.
@en
Patient-reported outcomes in s ...... oject phase III protocol B-32.
@nl
P2093
P2860
P356
P1476
Patient-reported outcomes in s ...... roject phase III protocol B-32
@en
P2093
Ann M Brown
David N Krag
Jacek A Kopec
Joseph P Costantino
Nicholas J Christian
Norman Wolmark
Patricia A Ganz
Stephanie R Land
Thomas B Julian
P2507
P2860
P304
P356
10.1200/JCO.2010.28.2491
P407
P577
2010-08-02T00:00:00Z